Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Prescribed burn associations are proving key to conservationists’ efforts to restore a longleaf pine range forming the backbone of forest ecology in the American Southeast.
The Centers for Disease Control and Prevention announced an urgent need to increase vaccination coverage in response to rising respiratory disease levels.
